Latest News and Press Releases

AVAVA Earns New FDA Clearance for the Treatment of Wrinkles The High-Energy Non-Ablative Platform Redefining What’s Possible in Skin Revitalization

NEWPORT BEACH, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- AVAVA, a next-generation aesthetics company, today announced it has been named the winner for Best Emerging Disruptor at the prestigious...

AVAVA™ receives FDA clearance for acne scar treatment on all skin types with its high-energy, non-ablative laser and Focal Point Technology™.

AVAVA™ receives FDA clearance for acne scar treatment on all skin types with its high-energy, non-ablative laser and Focal Point Technology™.

JAAD: Focal point technology: Controlling treatment depth and pattern of skin injury by a novel highly focused laser.

AVAVA™ appoints laser expert Dr. Rox Anderson to its Board, advancing innovation with Focal Point Technology™ for next-gen energy-based treatments.

WALTHAM, Mass., Dec. 07, 2022 (GLOBE NEWSWIRE) -- AVAVA Inc. (“AVAVA” or the “Company”), a disruptive medical aesthetics platform company advancing a new class of focused intradermal laser products...

WALTHAM, Mass., Aug. 17, 2022 (GLOBE NEWSWIRE) -- AVAVA Inc. (“AVAVA” or the “Company”), a disruptive medical aesthetics technology platform company providing breakthrough treatments for all skin...